Cargando…
Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans
Immunoglobulin G (IgG) mediates its immune functions through complement and cellular IgG-Fc receptors (FcγR). IgG contains an evolutionary conserved N-linked glycan at position Asn297 in the Fc-domain. This glycan consists of variable levels of fucose, galactose, sialic acid, and bisecting N-acetylg...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131652/ https://www.ncbi.nlm.nih.gov/pubmed/27872474 http://dx.doi.org/10.1038/srep36964 |
_version_ | 1782470939328380928 |
---|---|
author | Dekkers, Gillian Plomp, Rosina Koeleman, Carolien A. M. Visser, Remco von Horsten, Hans H. Sandig, Volker Rispens, Theo Wuhrer, Manfred Vidarsson, Gestur |
author_facet | Dekkers, Gillian Plomp, Rosina Koeleman, Carolien A. M. Visser, Remco von Horsten, Hans H. Sandig, Volker Rispens, Theo Wuhrer, Manfred Vidarsson, Gestur |
author_sort | Dekkers, Gillian |
collection | PubMed |
description | Immunoglobulin G (IgG) mediates its immune functions through complement and cellular IgG-Fc receptors (FcγR). IgG contains an evolutionary conserved N-linked glycan at position Asn297 in the Fc-domain. This glycan consists of variable levels of fucose, galactose, sialic acid, and bisecting N-acetylglucosamine (bisection). Of these variations, the lack of fucose strongly enhances binding to the human FcγRIII, a finding which is currently used to improve the efficacy of therapeutic monoclonal antibodies. The influence of the other glycan traits is largely unknown, mostly due to lack of glyco-engineering tools. We describe general methods to produce recombinant proteins of any desired glycoform in eukaryotic cells. Decoy substrates were used to decrease the level of fucosylation or galactosylation, glycosyltransferases were transiently overexpressed to enhance bisection, galactosylation and sialylation and in vitro sialylation was applied for enhanced sialylation. Combination of these techniques enable to systematically explore the biological effect of these glycosylation traits for IgG and other glycoproteins. |
format | Online Article Text |
id | pubmed-5131652 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51316522016-12-15 Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans Dekkers, Gillian Plomp, Rosina Koeleman, Carolien A. M. Visser, Remco von Horsten, Hans H. Sandig, Volker Rispens, Theo Wuhrer, Manfred Vidarsson, Gestur Sci Rep Article Immunoglobulin G (IgG) mediates its immune functions through complement and cellular IgG-Fc receptors (FcγR). IgG contains an evolutionary conserved N-linked glycan at position Asn297 in the Fc-domain. This glycan consists of variable levels of fucose, galactose, sialic acid, and bisecting N-acetylglucosamine (bisection). Of these variations, the lack of fucose strongly enhances binding to the human FcγRIII, a finding which is currently used to improve the efficacy of therapeutic monoclonal antibodies. The influence of the other glycan traits is largely unknown, mostly due to lack of glyco-engineering tools. We describe general methods to produce recombinant proteins of any desired glycoform in eukaryotic cells. Decoy substrates were used to decrease the level of fucosylation or galactosylation, glycosyltransferases were transiently overexpressed to enhance bisection, galactosylation and sialylation and in vitro sialylation was applied for enhanced sialylation. Combination of these techniques enable to systematically explore the biological effect of these glycosylation traits for IgG and other glycoproteins. Nature Publishing Group 2016-11-22 /pmc/articles/PMC5131652/ /pubmed/27872474 http://dx.doi.org/10.1038/srep36964 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Dekkers, Gillian Plomp, Rosina Koeleman, Carolien A. M. Visser, Remco von Horsten, Hans H. Sandig, Volker Rispens, Theo Wuhrer, Manfred Vidarsson, Gestur Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans |
title | Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans |
title_full | Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans |
title_fullStr | Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans |
title_full_unstemmed | Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans |
title_short | Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans |
title_sort | multi-level glyco-engineering techniques to generate igg with defined fc-glycans |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131652/ https://www.ncbi.nlm.nih.gov/pubmed/27872474 http://dx.doi.org/10.1038/srep36964 |
work_keys_str_mv | AT dekkersgillian multilevelglycoengineeringtechniquestogenerateiggwithdefinedfcglycans AT plomprosina multilevelglycoengineeringtechniquestogenerateiggwithdefinedfcglycans AT koelemancarolienam multilevelglycoengineeringtechniquestogenerateiggwithdefinedfcglycans AT visserremco multilevelglycoengineeringtechniquestogenerateiggwithdefinedfcglycans AT vonhorstenhansh multilevelglycoengineeringtechniquestogenerateiggwithdefinedfcglycans AT sandigvolker multilevelglycoengineeringtechniquestogenerateiggwithdefinedfcglycans AT rispenstheo multilevelglycoengineeringtechniquestogenerateiggwithdefinedfcglycans AT wuhrermanfred multilevelglycoengineeringtechniquestogenerateiggwithdefinedfcglycans AT vidarssongestur multilevelglycoengineeringtechniquestogenerateiggwithdefinedfcglycans |